Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037036 · ClinicalTrials.gov registry record · Phase 2
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
A Phase 2 study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01037036: Completed Phase 2 study, sponsored by Mati Therapeutics.
NCT01037036 is a Phase 2 study that has completed, run by Mati Therapeutics. The registered enrollment target is 15 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01037036, a Phase 2 study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.
Interventions
- DRUG Xalatan
- DRUG Latanoprost Punctal Plug Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
What the finished NCT01037036 record still lists
NCT01037036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Xalatan is the first listed.
NCT01037036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01037036 about?
NCT01037036 is a clinical study titled "A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG". The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.
What is the current status of trial NCT01037036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01037036?
The interventions under investigation include: Xalatan (DRUG), Latanoprost Punctal Plug Delivery System (DRUG).
Who is sponsoring clinical trial NCT01037036?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01037036's enrollment target sits among peer trials
15 1919th of 2000 higher than 60 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia